SCHEMBL31376923

SCHEMBL31376923

CCc1ccc(/C=C2\SC(=O)N(CCCC(=O)O)C2=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 3/20 0.68
▸ MAX P61244 2/20 0.60
▸ FFAR1 O14842 1/20 0.58
▸ RAB9A P51151 2/20 0.57
▸ HTT P42858 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ MITF O75030 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ HPGD P15428 1/20 0.57
▸ XBP1 P17861 1/20 0.57
▸ GFER P55789 1/20 0.57
▸ MMP1 P03956 1/20 0.57
▸ MMP2 P08253 1/20 0.57
▸ MMP13 P45452 1/20 0.57
▸ MMP14 P50281 1/20 0.57
▸ PTPN7 P35236 1/20 0.56
▸ PTPN12 Q05209 1/20 0.56
▸ GPR35 Q9HC97 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008430 0.88 MYC (0.76) MYCMAXFFAR1RAB9AHTT
SCHEMBL13446896 0.86 MMP1 (0.73) FFAR1RAB9AHTTSMN1; SMN2NPC1
SCHEMBL20534542 0.85 CA9 (0.74) FFAR1RAB9ANPC1MITFKMT2A
SCHEMBL20534442 0.85 CA9 (0.74) FFAR1RAB9ANPC1MITFKMT2A
SCHEMBL31376970 0.83 TDP1 (0.83) MYCRAB9ANPC1PTPN7PTPN12
SCHEMBL17927296 0.82 MYC (0.70) MYCMAXRAB9ASMN1; SMN2NPC1
SCHEMBL17927295 0.82 MYC (0.70) MYCMAXRAB9ASMN1; SMN2NPC1
SCHEMBL29214806 0.81 MMP1 (0.67) MYCFFAR1RAB9AHTTSMN1; SMN2
SCHEMBL29214808 0.81 MMP1 (0.67) MYCFFAR1RAB9AHTTSMN1; SMN2
SCHEMBL17927322 0.81 MAPK1 (0.71) MYCMAXMITFKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064325-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. (US) 2025-03-27 — — WO disclosed
Send feedback